TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 59 filers reported holding TALARIS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1 | -96.4% | 200 | -98.6% | 0.00% | – |
| Q1 2023 | $28 | +86.7% | 14,800 | 0.0% | 0.00% | – |
| Q4 2022 | $15 | -100.0% | 14,800 | 0.0% | 0.00% | – |
| Q3 2022 | $39,000 | -40.9% | 14,800 | +0.4% | 0.00% | – |
| Q2 2022 | $66,000 | -54.8% | 14,743 | -0.3% | 0.00% | – |
| Q1 2022 | $146,000 | -6.4% | 14,794 | +45.2% | 0.00% | – |
| Q4 2021 | $156,000 | +50.0% | 10,189 | +32.5% | 0.00% | – |
| Q3 2021 | $104,000 | -7.1% | 7,689 | +1.2% | 0.00% | – |
| Q2 2021 | $112,000 | – | 7,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 682,923 | $10,032,000 | 1.61% |
| SECTORAL ASSET MANAGEMENT INC | 711,000 | $10,445,000 | 0.84% |
| Logos Global Management LP | 507,923 | $7,461,000 | 0.63% |
| Artal Group S.A. | 2,064,262 | $30,324,000 | 0.62% |
| Cormorant Asset Management, LP | 1,215,847 | $17,264,000 | 0.59% |
| Eventide Asset Management | 1,561,092 | $22,411,000 | 0.30% |
| Blackstone Inc. | 8,089,315 | $118,832,000 | 0.27% |
| Avidity Partners Management LP | 436,363 | $6,410,000 | 0.17% |
| VIKING GLOBAL INVESTORS LP | 3,289,617 | $48,324,000 | 0.15% |
| HHLR ADVISORS, LTD. | 853,344 | $12,536,000 | 0.13% |